Max Healthcare Subsidiary Faces ₹165.7 Crore GST Tax Demand

BANKINGFINANCE
Whalesbook Logo
AuthorAarav Shah|Published at:
Max Healthcare Subsidiary Faces ₹165.7 Crore GST Tax Demand

Alps Hospital, a subsidiary of Max Healthcare Institute, has received a tax notice from the DGGI regarding GST on management fees. The total demand, including penalties, is approximately ₹165.7 crore. The company has stated it is preparing a formal response to contest these allegations.

Max Healthcare Institute has informed investors that its wholly-owned subsidiary, Alps Hospital Limited, received a show-cause-cum-demand notice from the Directorate General of Goods and Services Tax Intelligence (DGGI), Mumbai Zonal Unit. The notice, issued on August 25, 2026, alleges that the company failed to pay GST on variable management fees.

The tax authority has calculated a total potential financial exposure of approximately ₹165.7 crore. This figure includes a principal GST liability of ₹55.23 crore, accompanied by two separate penalty layers of ₹55.23 crore each, plus any applicable interest. It is important to note that this is a show-cause notice, which serves as a preliminary legal step rather than a final verdict or assessment of guilt. The company is now required to submit its arguments and evidence to the authorities to contest the demand.

For investors, the immediate concern is the potential impact on the company’s cash flow and profit margins if the tax demand is upheld. However, this must be balanced against the company’s scale of operations. Max Healthcare recently reported a quarterly profit after tax of ₹357 crore and an operating EBITDA of ₹704 crore. This indicates that while a liability of this size is significant, the company maintains a strong financial base to manage legal and operational contingencies.

This development highlights the ongoing regulatory scrutiny regarding how large hospital chains structure their inter-company transactions. Tax authorities are increasingly examining the classification of management fees to ensure compliance with the Central Goods and Services Tax Act. Because such arrangements are common in corporate groups to allocate costs, the outcome of this case may provide clarity for the broader healthcare sector regarding tax treatment of similar internal services.

Max Healthcare has confirmed that its legal and financial teams are currently drafting a comprehensive response. The next critical update for investors will be the outcome of the adjudication process, where the company will have the opportunity to present its legal position to the DGGI. There is no set timeline for the resolution, as these legal proceedings typically follow a formal timeline for submissions, hearings, and final orders.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.